Huaheng Biotech announced that the list of incentives granted for the first time in the company's 2026 restricted stock incentive plan was announced within the company from September 30 to October 9, 2026. The publicity period was 10 days, and no objections were received at the end of the period. After verification by the Remuneration and Assessment Committee of the Board of Directors, the first incentive recipients all met the requirements stipulated in relevant laws, regulations and incentive plans. They were legal and valid as incentive recipients. The incentive targets did not include independent directors, shareholders holding 5% or more of the shares, and relatives of actual controllers.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.